Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study

Michael R. Rickels; Katrina J. Ruedy; Nicole C. Foster; Claude A. Piché; Helene Dulude; Jennifer L. Sherr; William V. Tamborlane; Kathleen E. Bethin; Linda A. DiMeglio; R. Paul Wadwa; Andrew J. Ahmann; Michael J. Haller; Brandon M. Nathan; Santica M. Marcovina; Emmanouil Rampakakis; Linyan Meng; Roy W. Beck

doi:10.2337/dci16-0025

Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study

Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Helene Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck

Pediatrics - Endocrine and Diabetes

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	e193-e194
Journal	Diabetes care
Volume	39
Issue number	10
DOIs	https://doi.org/10.2337/dci16-0025
State	Published - Oct 1 2016

Bibliographical note

Funding Information:
This work was funded by a grant from the Leona M. and Harry B. Helmsley Charitable Trust; by the National Center for Research Resourcesand theNationalCenter forAdvancing Translational Sciences, National Institutes of Health, throughgrantsUL1TR000003 (University of Pennsylvania), UL1TR000064 (University of Florida), and UL1TR001108 (Indiana University); and by Locemia Solutions ULC. Studies at the Barbara Davis Center for Childhood Diabetes were performed in their infusion center and not the hospital Clinical Translational Research Center. Locemia Solutions provided the intranasal glucagon product.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.2337/dci16-0025

OpenUrl availability

Full text

Cite this

Rickels, M. R., Ruedy, K. J., Foster, N. C., Piché, C. A., Dulude, H., Sherr, J. L., Tamborlane, W. V., Bethin, K. E., DiMeglio, L. A., Wadwa, R. P., Ahmann, A. J., Haller, M. J., Nathan, B. M., Marcovina, S. M., Rampakakis, E., Meng, L., & Beck, R. W. (2016). Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study. Diabetes care, 39(10), e193-e194. https://doi.org/10.2337/dci16-0025

Rickels, MR, Ruedy, KJ, Foster, NC, Piché, CA, Dulude, H, Sherr, JL, Tamborlane, WV, Bethin, KE, DiMeglio, LA, Wadwa, RP, Ahmann, AJ, Haller, MJ, Nathan, BM, Marcovina, SM, Rampakakis, E, Meng, L & Beck, RW 2016, 'Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study', Diabetes care, vol. 39, no. 10, pp. e193-e194. https://doi.org/10.2337/dci16-0025

@article{5d44edde6f2d47e097db7f1ce4d63711,

title = "Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study",

author = "Rickels, {Michael R.} and Ruedy, {Katrina J.} and Foster, {Nicole C.} and Pich{\'e}, {Claude A.} and Helene Dulude and Sherr, {Jennifer L.} and Tamborlane, {William V.} and Bethin, {Kathleen E.} and DiMeglio, {Linda A.} and Wadwa, {R. Paul} and Ahmann, {Andrew J.} and Haller, {Michael J.} and Nathan, {Brandon M.} and Marcovina, {Santica M.} and Emmanouil Rampakakis and Linyan Meng and Beck, {Roy W.}",

note = "Funding Information: This work was funded by a grant from the Leona M. and Harry B. Helmsley Charitable Trust; by the National Center for Research Resourcesand theNationalCenter forAdvancing Translational Sciences, National Institutes of Health, throughgrantsUL1TR000003 (University of Pennsylvania), UL1TR000064 (University of Florida), and UL1TR001108 (Indiana University); and by Locemia Solutions ULC. Studies at the Barbara Davis Center for Childhood Diabetes were performed in their infusion center and not the hospital Clinical Translational Research Center. Locemia Solutions provided the intranasal glucagon product.",

year = "2016",

month = oct,

day = "1",

doi = "10.2337/dci16-0025",

language = "English (US)",

volume = "39",

pages = "e193--e194",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "10",

}

TY - JOUR

T1 - Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes

T2 - A randomized crossover noninferiority study

AU - Rickels, Michael R.

AU - Ruedy, Katrina J.

AU - Foster, Nicole C.

AU - Piché, Claude A.

AU - Dulude, Helene

AU - Sherr, Jennifer L.

AU - Tamborlane, William V.

AU - Bethin, Kathleen E.

AU - DiMeglio, Linda A.

AU - Wadwa, R. Paul

AU - Ahmann, Andrew J.

AU - Haller, Michael J.

AU - Nathan, Brandon M.

AU - Marcovina, Santica M.

AU - Rampakakis, Emmanouil

AU - Meng, Linyan

AU - Beck, Roy W.

N1 - Funding Information: This work was funded by a grant from the Leona M. and Harry B. Helmsley Charitable Trust; by the National Center for Research Resourcesand theNationalCenter forAdvancing Translational Sciences, National Institutes of Health, throughgrantsUL1TR000003 (University of Pennsylvania), UL1TR000064 (University of Florida), and UL1TR001108 (Indiana University); and by Locemia Solutions ULC. Studies at the Barbara Davis Center for Childhood Diabetes were performed in their infusion center and not the hospital Clinical Translational Research Center. Locemia Solutions provided the intranasal glucagon product.

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=84988926887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988926887&partnerID=8YFLogxK

U2 - 10.2337/dci16-0025

DO - 10.2337/dci16-0025

M3 - Letter

C2 - 27660135

AN - SCOPUS:84988926887

SN - 0149-5992

VL - 39

SP - e193-e194

JO - Diabetes care

JF - Diabetes care

IS - 10

ER -

Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this